Prof. Dan Aderka, Head of the Gastrointestinal Cancer Service at Sheba, recently conducted research that brought an end to a long-standing controversy over the treatment regimen for Colorectal Cancer (CRC) patients. The study discovered that various combinations of chemotherapy and biological medicine directly affected the life expectancy of CRC patients, depending on the specific type of tumor.
A clinical trial to test a new palliative care technique for patients with upper abdominal cancer is underway at Sheba Medical Center – and the significant results are encouraging.
Dr. Golan’s research offers new hope for patients worldwide with pancreatic cancer, particularly pancreatic adenocarcinoma harboring BRCA mutations. The results showed that patients who received the POLO treatment did significantly better overall than those who did not receive the drug.
Researchers at Sheba Medical Center are advancing rapidly towards a cure for hemophilia, a bleeding disorder that prevents normal blood clotting. At present, more than 400,000 individuals suffer from hemophilia around the globe.
The WINTHER trial reveals that using a combination of RNA profiling and DNA alterations testing can match personalized therapies to more patients suffering with advanced cancer than only using DNA profiling for tumor mutations.
A ravaging house fire left 18-month old Shams Ismail in critical condition, with burns on over 50% of her small body. She was rushed to the National Burn Unit at Sheba Medical Center, where top experts saved her life.
For the past six years, Forbes has compiled an annual list of the best doctors in Israel. Medical professionals from across Israel are asked to recommend physicians from other medical institutions and specializations, and once again, Sheba’s doctors compose a long list of specialists at the top.
In a groundbreaking joint study, Sheba researchers and U.S. scientists from Harvard T.H. Chan School of Public Health, Brigham and Women’s Hospital in Boston, uncovered a connection between propionate, a chemical preservative commonly used in food, and the increased worldwide rates of obesity and diabetes. The results of the study were published recently in the Science Translational Medical Journal.
When our twins were born on October 16, 2012, we could not even imagine the troubles we were going to face. Our son Stepan and daughter Lera were born strong and healthy. We were discharged home after six days, full of joy and without any signs of trouble.
Doctors from Sheba Medical Center and Mayo Clinic Medical Center in Minnesota, US, recently convened in Israel. The March 2019 conference is the fifth time that these premier, world-renowned healthcare centers joined together to fortify and advance their cooperative ventures in research, technological innovation, and clinical practice. The focus of this meeting was to discuss the newest issues in the fields of cardiology and nephrology.
Established in 1948, Sheba Medical Center is now the leading medical center in the region.
